{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:43:25Z","timestamp":1794408205619,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31970821"],"award-info":[{"award-number":["31970821"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Program of National Key Research and Development","award":["2017YFE0122900"],"award-info":[{"award-number":["2017YFE0122900"]}]},{"name":"The Program of National Key Research and Development","award":["2017YFA0105000"],"award-info":[{"award-number":["2017YFA0105000"]}]},{"name":"The Program of National Key Research and Development","award":["2018YFA0108400"],"award-info":[{"award-number":["2018YFA0108400"]}]},{"name":"The Program of National Key Research and Development","award":["2018YFA0108500"],"award-info":[{"award-number":["2018YFA0108500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Midbrain dopaminergic (DA) progenitors derived from human pluripotent stem cells are considered to be a promising treatment for Parkinson\u2019s disease (PD). However, the differentiation process produces undesired cell types, which influence the in vivo evaluation of DA cells. In this paper, we analyze the cell fate choice during differentiation and provide valuable information on cell preparation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Human embryonic stem cells were differentiated into DA progenitors. We applied single-cell RNA sequencing (scRNA-seq) of the differentiation cells at different time points and investigated the gene expression profiles. Based on the differentially expressed genes between DA and non-DA cells, we investigated the impact of <jats:italic>LGI1<\/jats:italic> (DA enriched) overexpression on DA differentiation and the enrichment effect of CD99 (non-DA enriched) sorting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Transcriptome analyses revealed the DA differentiation trajectory as well as non-DA populations and three key lineage branch points. Using genetic gain- and loss-of-function approaches, we found that overexpression of <jats:italic>LGI1<\/jats:italic>, which is specific to EN1<jats:sup>+<\/jats:sup> early DA progenitors, can promote the generation of TH<jats:sup>+<\/jats:sup> neurons. We also found that choroid plexus epithelial cells and DA progenitors are major components of the final product (day 25), and CD99 was a specific surface marker of choroid plexus epithelial cells. Sorting of CD99<jats:sup>\u2212<\/jats:sup> cells eliminated major contaminant cells and improved the purity of DA progenitors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study provides the single-cell transcriptional landscape of in vitro DA differentiation, which can guide future improvements in DA preparation and quality control for PD cell therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-022-03104-7","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T06:02:45Z","timestamp":1660370565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Single-cell transcriptomics reveals the cell fate transitions of human dopaminergic progenitors derived from hESCs"],"prefix":"10.1186","volume":"13","author":[{"given":"Lingmin","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glyn Nigel","family":"Stacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ng","family":"Shyh-Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0524-6865","authenticated-orcid":false,"given":"Yukai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"issue":"9423","key":"3104_CR1","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii A, Nutt JG, Ransom BR. Parkinson\u2019s disease. Lancet. 2004;363(9423):1783\u201393.","journal-title":"Lancet"},{"issue":"1","key":"3104_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","volume":"5","author":"E Tolosa","year":"2006","unstructured":"Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson\u2019s disease. Lancet Neurol. 2006;5(1):75\u201386.","journal-title":"Lancet Neurol"},{"issue":"4","key":"3104_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.pneurobio.2008.05.003","volume":"85","author":"A Toulouse","year":"2008","unstructured":"Toulouse A, Sullivan AM. Progress in Parkinson\u2019s disease-where do we stand? Prog Neurobiol. 2008;85(4):376\u201392.","journal-title":"Prog Neurobiol"},{"issue":"5","key":"3104_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.tips.2009.03.001","volume":"30","author":"O Lindvall","year":"2009","unstructured":"Lindvall O, Kokaia Z. Prospects of stem cell therapy for replacing dopamine neurons in Parkinson\u2019s disease. Trends Pharmacol Sci. 2009;30(5):260\u20137.","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"3104_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM. Epidemiology of Parkinson\u2019s disease. Lancet Neurol. 2006;5(6):525\u201335.","journal-title":"Lancet Neurol"},{"issue":"12","key":"3104_CR6","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1002\/cne.23577","volume":"522","author":"PC Buttery","year":"2014","unstructured":"Buttery PC, Barker RA. Treating Parkinson\u2019s disease in the 21st century: can stem cell transplantation compete? J Comp Neurol. 2014;522(12):2802\u201316.","journal-title":"J Comp Neurol"},{"issue":"10","key":"3104_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1056\/NEJM200103083441011","volume":"344","author":"GD Fischbach","year":"2001","unstructured":"Fischbach GD, McKhann GM. Cell therapy for Parkinson\u2019s disease. N Engl J Med. 2001;344(10):763\u20135.","journal-title":"N Engl J Med"},{"issue":"Pt 7","key":"3104_CR8","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/brain\/awh510","volume":"128","author":"I Mendez","year":"2005","unstructured":"Mendez I, et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson\u2019s disease. Brain. 2005;128(Pt 7):1498\u2013510.","journal-title":"Brain"},{"issue":"23","key":"3104_CR9","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1073\/pnas.1605245113","volume":"113","author":"W Li","year":"2016","unstructured":"Li W, et al. Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain. Proc Natl Acad Sci USA. 2016;113(23):6544\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3104_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archneur.1989.00520420033021","volume":"46","author":"O Lindvall","year":"1989","unstructured":"Lindvall O, et al. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson\u2019s disease: a detailed account of methodology and a 6-month follow-up. Arch Neurol. 1989;46(6):615\u201331.","journal-title":"Arch Neurol"},{"issue":"22","key":"3104_CR11","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1056\/NEJM199211263272202","volume":"327","author":"CR Freed","year":"1992","unstructured":"Freed CR, et al. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson\u2019s disease. N Engl J Med. 1992;327(22):1549\u201355.","journal-title":"N Engl J Med"},{"issue":"22","key":"3104_CR12","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJM199211263272201","volume":"327","author":"DD Spencer","year":"1992","unstructured":"Spencer DD, et al. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson\u2019s disease. N Engl J Med. 1992;327(22):1541\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"3104_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1001\/jamaneurol.2013.4749","volume":"71","author":"Z Kefalopoulou","year":"2014","unstructured":"Kefalopoulou Z, et al. Long-term clinical outcome of fetal cell transplantation for Parkinson disease: two case reports. JAMA Neurol. 2014;71(1):83\u20137.","journal-title":"JAMA Neurol"},{"issue":"2","key":"3104_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/archneur.56.2.179","volume":"56","author":"RA Hauser","year":"1999","unstructured":"Hauser RA, et al. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol. 1999;56(2):179\u201387.","journal-title":"Arch Neurol"},{"issue":"2","key":"3104_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s41583-019-0257-7","volume":"21","author":"M Parmar","year":"2020","unstructured":"Parmar M, Grealish S, Henchcliffe C. The future of stem cell therapies for Parkinson disease. Nat Rev Neurosci. 2020;21(2):103\u201315.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"3104_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/ejn.14109","volume":"49","author":"M Parmar","year":"2019","unstructured":"Parmar M, Torper O, Drouin-Ouellet J. Cell-based therapy for Parkinson\u2019s disease: a journey through decades toward the light side of the force. Eur J Neurosci. 2019;49(4):463\u201371.","journal-title":"Eur J Neurosci"},{"key":"3104_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2018.04.005","volume":"168","author":"KC Sonntag","year":"2018","unstructured":"Sonntag KC, et al. Pluripotent stem cell-based therapy for Parkinson\u2019s disease: current status and future prospects. Prog Neurobiol. 2018;168:1\u201320.","journal-title":"Prog Neurobiol"},{"issue":"2","key":"3104_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.stem.2021.01.005","volume":"28","author":"TW Kim","year":"2021","unstructured":"Kim TW, et al. Biphasic activation of WNT signaling facilitates the derivation of midbrain dopamine neurons from hESCs for translational use. Cell Stem Cell. 2021;28(2):343-355.e5.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"3104_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.stemcr.2014.01.013","volume":"2","author":"D Doi","year":"2014","unstructured":"Doi D, et al. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation. Stem Cell Reports. 2014;2(3):337\u201350.","journal-title":"Stem Cell Reports"},{"issue":"7378","key":"3104_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks S, et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease. Nature. 2011;480(7378):547\u201351.","journal-title":"Nature"},{"issue":"6","key":"3104_CR21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.celrep.2012.04.009","volume":"1","author":"A Kirkeby","year":"2012","unstructured":"Kirkeby A, et al. Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions. Cell Rep. 2012;1(6):703\u201314.","journal-title":"Cell Rep"},{"issue":"2","key":"3104_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.stem.2021.01.004","volume":"28","author":"J Piao","year":"2021","unstructured":"Piao J, et al. Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01. Cell Stem Cell. 2021;28(2):217-229.e7.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3104_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.stemcr.2018.05.010","volume":"11","author":"YK Wang","year":"2018","unstructured":"Wang YK, et al. Human clinical-grade parthenogenetic esc-derived dopaminergic neurons recover locomotive defects of nonhuman primate models of Parkinson\u2019s disease. Stem Cell Reports. 2018;11(1):171\u201382.","journal-title":"Stem Cell Reports"},{"issue":"7669","key":"3104_CR24","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nature23664","volume":"548","author":"T Kikuchi","year":"2017","unstructured":"Kikuchi T, et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson\u2019s disease model. Nature. 2017;548(7669):592\u20136.","journal-title":"Nature"},{"issue":"2","key":"3104_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1172\/JCI130767","volume":"130","author":"B Song","year":"2020","unstructured":"Song B, et al. Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson\u2019s disease models. J Clin Invest. 2020;130(2):904\u201320.","journal-title":"J Clin Invest"},{"issue":"20","key":"3104_CR26","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1915872","volume":"382","author":"JS Schweitzer","year":"2020","unstructured":"Schweitzer JS, et al. Personalized iPSC-derived dopamine progenitor cells for parkinson\u2019s disease. N Engl J Med. 2020;382(20):1926\u201332.","journal-title":"N Engl J Med"},{"key":"3104_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3389\/fcell.2020.00729","volume":"8","author":"TW Kim","year":"2020","unstructured":"Kim TW, Koo SY, Studer L. Pluripotent stem cell therapies for parkinson disease: present challenges and future opportunities. Front Cell Dev Biol. 2020;8:729.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"3104_CR28","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1038\/nprot.2017.078","volume":"12","author":"S Nolbrant","year":"2017","unstructured":"Nolbrant S, et al. Generation of high-purity human ventral midbrain dopaminergic progenitors for in vitro maturation and intracerebral transplantation. Nat Protoc. 2017;12(9):1962\u201379.","journal-title":"Nat Protoc"},{"issue":"1","key":"3104_CR29","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1038\/s41467-020-16225-5","volume":"11","author":"K Tiklov\u00e1","year":"2020","unstructured":"Tiklov\u00e1 K, et al. Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson\u2019s disease. Nat Commun. 2020;11(1):2434.","journal-title":"Nat Commun"},{"issue":"1","key":"3104_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/cells10010137","volume":"10","author":"F Nilsson","year":"2021","unstructured":"Nilsson F, et al. Single-cell profiling of coding and noncoding genes in human dopamine neuron differentiation. Cells. 2021;10(1):137.","journal-title":"Cells"},{"issue":"4","key":"3104_CR31","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41591-021-01257-1","volume":"27","author":"Y Tao","year":"2021","unstructured":"Tao Y, et al. Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys. Nat Med. 2021;27(4):632\u20139.","journal-title":"Nat Med"},{"key":"3104_CR32","doi-asserted-by":"publisher","first-page":"14049","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng GX, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 2017;8:14049.","journal-title":"Nat Commun"},{"issue":"7","key":"3104_CR33","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, et al. Comprehensive integration of single-cell data. Cell. 2019;177(7):1888-1902.e21.","journal-title":"Cell"},{"issue":"12","key":"3104_CR34","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16(12):1289\u201396.","journal-title":"Nat Methods"},{"key":"3104_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","volume":"37","author":"E Becht","year":"2018","unstructured":"Becht E, et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol. 2018;37:38.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"3104_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136.","journal-title":"Nat Biotechnol"},{"issue":"10","key":"3104_CR37","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14(10):979\u201382.","journal-title":"Nat Methods"},{"issue":"3","key":"3104_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1042\/AN20120095","volume":"5","author":"L Kegel","year":"2013","unstructured":"Kegel L, et al. LGI proteins in the nervous system. ASN Neuro. 2013;5(3):167\u201381.","journal-title":"ASN Neuro"},{"issue":"1","key":"3104_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12311-014-0628-6","volume":"14","author":"LD Su","year":"2015","unstructured":"Su LD, et al. LGI1 is involved in the development of mouse brain. Cerebellum. 2015;14(1):12\u20134.","journal-title":"Cerebellum"},{"issue":"19","key":"3104_CR40","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.1523\/JNEUROSCI.5147-09.2010","volume":"30","author":"R Thomas","year":"2010","unstructured":"Thomas R, et al. LGI1 is a Nogo receptor 1 ligand that antagonizes myelin-based growth inhibition. J Neurosci. 2010;30(19):6607\u201312.","journal-title":"J Neurosci"},{"key":"3104_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s42466-020-0053-x","volume":"2","author":"F G\u00f6vert","year":"2020","unstructured":"G\u00f6vert F, et al. Antibody-related movement disorders - a comprehensive review of phenotype-autoantibody correlations and a guide to testing. Neurol Res Pract. 2020;2:6.","journal-title":"Neurol Res Pract"},{"issue":"10","key":"3104_CR42","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.parkreldis.2015.08.014","volume":"21","author":"MM Kurtis","year":"2015","unstructured":"Kurtis MM, et al. Immunomodulated parkinsonism as a presenting symptom of LGI1 antibody encephalitis. Parkinsonism Relat Disord. 2015;21(10):1286\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"3104_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neuron.2015.03.002","volume":"86","author":"JA Steinbeck","year":"2015","unstructured":"Steinbeck JA, Studer L. Moving stem cells to the clinic: potential and limitations for brain repair. Neuron. 2015;86(1):187\u2013206.","journal-title":"Neuron"},{"issue":"11","key":"3104_CR44","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1016\/j.stemcr.2021.09.014","volume":"16","author":"T Oosterveen","year":"2021","unstructured":"Oosterveen T, et al. Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson\u2019s disease. Stem Cell Reports. 2021;16(11):2718\u201335.","journal-title":"Stem Cell Reports"},{"issue":"2","key":"3104_CR45","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2016.09.027","volume":"167","author":"G La Manno","year":"2016","unstructured":"La Manno G, et al. Molecular diversity of midbrain development in mouse, human, and stem cells. Cell. 2016;167(2):566-580.e19.","journal-title":"Cell"},{"issue":"1","key":"3104_CR46","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.1038\/s41467-021-27464-5","volume":"12","author":"A Fiorenzano","year":"2021","unstructured":"Fiorenzano A, et al. Single-cell transcriptomics captures features of human midbrain development and dopamine neuron diversity in brain organoids. Nat Commun. 2021;12(1):7302.","journal-title":"Nat Commun"},{"issue":"3","key":"3104_CR47","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41588-021-00801-6","volume":"53","author":"J Jerber","year":"2021","unstructured":"Jerber J, et al. Population-scale single-cell RNA-seq profiling across dopaminergic neuron differentiation. Nat Genet. 2021;53(3):304\u201312.","journal-title":"Nat Genet"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03104-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-022-03104-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-022-03104-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T07:33:10Z","timestamp":1660375990000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-022-03104-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3104"],"URL":"https:\/\/doi.org\/10.1186\/s13287-022-03104-7","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"19 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Animal and Medical Ethics Committee, Institute of Zoology, Chinese Academy of Sciences. The collection and processing of hESCs line Q-CTS-hESC-2 raw material was approved by the Ethical Committee of the First Affiliated Hospital of Nanjing Medical University. The use of animals was approved by the Institutional Animal Care and Use Committee (IACUC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"412"}}